Cargando…
Hepatic steatosis in patients with HIV-Hepatitis C Virus coinfection: is it associated with antiretroviral therapy and more advanced hepatic fibrosis?
BACKGROUND AND AIMS: Patients with HIV and hepatitis C virus (HCV) coinfection are at increased risk of developing hepatic steatosis. The aims of this study were to assess the prevalence of steatosis in a cohort with HIV-HCV coinfection, and to determine an association, if any, between steatosis, an...
Autores principales: | Verma, Sumita, Goldin, Robert D, Main, Janice |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527001/ https://www.ncbi.nlm.nih.gov/pubmed/18710499 http://dx.doi.org/10.1186/1756-0500-1-46 |
Ejemplares similares
-
Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen
por: Aurpibul, Linda, et al.
Publicado: (2019) -
Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valrie, et al.
Publicado: (2012) -
Hepatic steatosis in HIV-HCV coinfected patients receiving
antiretroviral therapy is associated with HCV-related factors but not
antiretrovirals
por: Martinez, Valérie, et al.
Publicado: (2013) -
Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection
por: Fernandez-Fuertes, M., et al.
Publicado: (2020) -
Hepatic steatosis and fibrosis: Non-invasive assessment
por: Karanjia, Rustam N, et al.
Publicado: (2016)